Paul Clancy
2018
In 2018, Paul Clancy earned a total compensation of $5.5M as Executive Vice President and Chief Financial Officer at Alexion Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,260,000 |
|---|---|
| Salary | $900,000 |
| Stock Awards | $3,302,761 |
| Other | $23,752 |
| Total | $5,486,513 |
Clancy received $3.3M in stock awards, accounting for 60% of the total pay in 2018.
Clancy also received $1.3M in non-equity incentive plan, $900K in salary and $23.8K in other compensation.
Rankings
In 2018, Paul Clancy's compensation ranked 1,768th out of 14,244 executives tracked by ExecPay. In other words, Clancy earned more than 87.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,768 out of 14,244 | 88th |
Division Manufacturing | 629 out of 5,759 | 89th |
Major group Chemicals And Allied Products | 202 out of 2,122 | 91st |
Industry group Drugs | 159 out of 1,811 | 91st |
Industry Pharmaceutical Preparations | 119 out of 1,385 | 91st |
Source: SEC filing on March 26, 2019.
Clancy's colleagues
We found five more compensation records of executives who worked with Paul Clancy at Alexion Pharmaceuticals in 2018.
2018
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2018
Julie O'Neill
Alexion Pharmaceuticals
Former Executive Vice President of Global Operations
2018
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Patient and Employee Experience Officer
2018
Brian Goff
Alexion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2018
John Orloff
Alexion Pharmaceuticals